VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma.
Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma. Clin Cancer Res. 2018 07 15; 24(14):3386-3396.
View in:
PubMed
subject areas
Animals
Antigen Presentation
Antigen-Presenting Cells
Antineoplastic Agents, Immunological
Biological Transport
Cell Line, Tumor
Complement Activation
Cross-Priming
Cytotoxicity, Immunologic
Disease Models, Animal
HLA-A2 Antigen
Humans
Immunologic Factors
Immunomodulation
Mice
Multiple Myeloma
Peptide Fragments
Proteasome Endopeptidase Complex
T-Lymphocytes, Cytotoxic
Xenograft Model Antitumor Assays
authors with profiles
JEFFREY J MOLLDREM
QING MA
GHEATH AL-ATRASH
ELIZABETH ANN MITTENDORF
JINSHENG WENG
KEN HE YOUNG
HAVEN REBECCA GARBER
SIJIE LU